Literature DB >> 23952745

Relative respiratory syncytial virus cytopathogenesis in upper and lower respiratory tract epithelium.

Hong Guo-Parke1, Paul Canning, Isobel Douglas, Rémi Villenave, Liam G Heaney, Peter V Coyle, Jeremy D Lyons, Michael D Shields, Ultan F Power.   

Abstract

RATIONALE: Respiratory syncytial virus (RSV) is a major pathogen that primarily infects airway epithelium. Most infants suffer mild upper respiratory tract (URT) symptoms, whereas approximately one-third progress to lower respiratory tract (LRT) involvement. Despite the ubiquity of URT infection, little is known about the relative cytopathogenesis of RSV infection in infant URT and LRT.
OBJECTIVES: This study aimed to compare RSV cytopathogenesis in nasal- and bronchial-derived epithelium from the same individuals using novel models derived from well-differentiated primary pediatric nasal (WD-PNECs) and bronchial epithelial cells (WD-PBECs).
METHODS: WD-PNECs and WD-PBECs were generated from nasal and bronchial brushes, respectively, and mock-infected or infected with RSV BT2a. RSV tropism, infectivity, cytopathology, growth kinetics, cell sloughing, apoptosis, and cytokine and chemokine responses were determined.
MEASUREMENTS AND MAIN RESULTS: RSV infection in both cultures was restricted to apical ciliated cells and occasional nonciliated cells but not goblet cells. It did not cause gross cytopathology. Infection resulted in apical release of progeny virus, increased apical cell sloughing, apoptosis, and occasional syncytia. RSV growth kinetics and peak titers were higher in WD-PBECs, coincident with higher ciliated cell contents, cell sloughing, and slightly compromised tight junctions. However, proinflammatory chemokine responses were similar for both cultures. Also, lambda IFNs, especially IL-29, were induced by RSV infection.
CONCLUSIONS: RSV induced remarkably similar, albeit quantitatively lower, cytopathogenesis and proinflammatory responses in WD-PNECs compared with WD-PBECs that reproduce many hallmarks of RSV pathogenesis in infants. WD-PNECs may provide an authentic surrogate model with which to study RSV cytopathogenesis in infant airway epithelium.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23952745     DOI: 10.1164/rccm.201304-0750OC

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN: 1073-449X            Impact factor:   21.405


  40 in total

1.  Comparative Therapeutic Potential of ALX-0171 and Palivizumab against Respiratory Syncytial Virus Clinical Isolate Infection of Well-Differentiated Primary Pediatric Bronchial Epithelial Cell Cultures.

Authors:  Lindsay Broadbent; Hong Guo Parke; Lyndsey J Ferguson; Andrena Millar; Michael D Shields; Laurent Detalle; Ultan F Power
Journal:  Antimicrob Agents Chemother       Date:  2020-01-27       Impact factor: 5.191

2.  Antibody-Induced Internalization of the Human Respiratory Syncytial Virus Fusion Protein.

Authors:  A Leemans; M De Schryver; W Van der Gucht; A Heykers; I Pintelon; A L Hotard; M L Moore; J A Melero; J S McLellan; B S Graham; L Broadbent; U F Power; G Caljon; P Cos; L Maes; P Delputte
Journal:  J Virol       Date:  2017-06-26       Impact factor: 5.103

Review 3.  Infant Immune Response to Respiratory Viral Infections.

Authors:  Santtu Heinonen; Rosa Rodriguez-Fernandez; Alejandro Diaz; Silvia Oliva Rodriguez-Pastor; Octavio Ramilo; Asuncion Mejias
Journal:  Immunol Allergy Clin North Am       Date:  2019-05-15       Impact factor: 3.479

4.  Induction and Antagonism of Antiviral Responses in Respiratory Syncytial Virus-Infected Pediatric Airway Epithelium.

Authors:  Rémi Villenave; Lindsay Broadbent; Isobel Douglas; Jeremy D Lyons; Peter V Coyle; Michael N Teng; Ralph A Tripp; Liam G Heaney; Michael D Shields; Ultan F Power
Journal:  J Virol       Date:  2015-09-30       Impact factor: 5.103

5.  Recurrent Respiratory Syncytial Virus Infection in a CD14-Deficient Patient.

Authors:  Sjanna B Besteman; Emily Phung; Henriette H M Raeven; Gimano D Amatngalim; Matevž Rumpret; Juliet Crabtree; Rutger M Schepp; Lisa W Rodenburg; Susanna G Siemonsma; Nile Verleur; Rianne van Slooten; Karen Duran; Gijs W van Haaften; Jeffrey M Beekman; Lauren A Chang; Linde Meyaard; Tjomme van der Bruggen; Guy A M Berbers; Nicole Derksen; Stefan Nierkens; Kaitlyn M Morabito; Tracy J Ruckwardt; Evelyn A Kurt-Jones; Douglas Golenbock; Barney S Graham; Louis J Bont
Journal:  J Infect Dis       Date:  2022-08-24       Impact factor: 7.759

6.  Disruption of the airway epithelial barrier in a murine model of respiratory syncytial virus infection.

Authors:  Carrie C Smallcombe; Debra T Linfield; Terri J Harford; Vladimir Bokun; Andrei I Ivanov; Giovanni Piedimonte; Fariba Rezaee
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2018-11-29       Impact factor: 5.464

Review 7.  Lamb model of respiratory syncytial virus-associated lung disease: insights to pathogenesis and novel treatments.

Authors:  Mark R Ackermann
Journal:  ILAR J       Date:  2014

8.  Conditional reprogramming of pediatric airway epithelial cells: A new human model to investigate early-life respiratory disorders.

Authors:  S Wolf; G F Perez; L Mukharesh; N Isaza; D Preciado; R J Freishtat; D Pillai; M C Rose; G Nino
Journal:  Pediatr Allergy Immunol       Date:  2017-11-22       Impact factor: 6.377

9.  Human Respiratory Syncytial Virus Subgroup A and B Infections in Nasal, Bronchial, Small-Airway, and Organoid-Derived Respiratory Cultures.

Authors:  L C Rijsbergen; M M Lamers; A D Comvalius; R W Koutstaal; D Schipper; W P Duprex; B L Haagmans; R D de Vries; R L de Swart
Journal:  mSphere       Date:  2021-05-12       Impact factor: 4.389

10.  Differentiation of Th subsets inhibited by nonstructural proteins of respiratory syncytial virus is mediated by ubiquitination.

Authors:  Ling Qin; Dan Peng; Chengping Hu; Yang Xiang; Yigang Zhou; Yurong Tan; Xiaoqun Qin
Journal:  PLoS One       Date:  2014-07-03       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.